XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2013-00324
- Event Type
- Injury
- Date Received
- January 17, 2013
- Date of Event
- December 26, 2012
- Report Date
- December 26, 2012
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- NIQ
- PMA / PMN Number
- P070015
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). ABOVE RATED BURST PRESSURE (RBP). THERE WERE NO REPORTED PRODUCT DEFICIENCIES. DISSECTION IS LISTED IN THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE (IFU) AS A KNOWN ADVERSE EVENT. IT SHOULD BE NOTED THAT THE IFU STATES: DO NOT EXCEED THE LABELED RBP. USE OF PRESSURES HIGHER THAN SPECIFIED MAY RESULT IN A RUPTURED BALLOON WITH POSSIBLE INTIMAL DAMAGE AND DISSECTION. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A 98% STENOSED LESION IN THE PROXIMAL RIGHT CORONARY ARTERY WITH MILD TORTUOSITY AND HEAVY CALCIFICATION. PRE-DILATATION WAS PERFORMED AND THE 3.0 X 23 MM XIENCE V STENT DELIVERY SYSTEM (SDS) WAS ADVANCED WITHOUT RESISTANCE. THE SDS WAS INFLATED ONE TIME AT 18 ATMOSPHERES (ATM), AND THE STENT WAS DEPLOYED. IT WAS THEN NOTED THAT A DISSECTION OCCURRED. THE PATIENT WAS SENT TO SURGERY FOR TREATMENT OF THE DISSECTION AND THE LESION. THE PATIENT HAD A GOOD OUTCOME. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 25791 | XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM | DRUG ELUTING CORONARY STENT SYSTEM | NIQ | AV-TEMECULA-CT | 2072041 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 58 YR | Hospitalization| R |